Traphaco JSC (HOSE:TRA)

Market Cap	2.78T
Revenue (ttm)	2.44T
Net Income (ttm)	197.54B
Shares Out	41.45M
EPS (ttm)	4,765.64
PE Ratio	14.06
Forward PE	n/a
Dividend	4,000.00 (5.98%)
Ex-Dividend Date	Jun 13, 2025

Volume	2,015
Average Volume	3,432
Open	66,500
Previous Close	67,000
Day's Range	66,500 - 66,900
52-Week Range	65,000 - 82,100
Beta	0.14
RSI	46.24
Earnings Date	Oct 29, 2025

About Traphaco JSC

Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases, nutritional food products, and medicines derived from medicinal herbs; trading in medicines, pharmaceuticals, vaccines-biological products, chemicals,...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 1,670
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: TRA

Financial Performance

In 2024, Traphaco JSC's revenue was 2.35 trillion, an increase of 2.09% compared to the previous year's 2.30 trillion. Earnings were 206.83 billion, a decrease of -9.60%.